RT Book, Section A1 Gurgle, Holly E. A1 Blumenthal, Donald K. A2 Brunton, Laurence L. A2 Hilal-Dandan, Randa A2 Knollmann, Björn C. SR Print(0) ID 1162539363 T1 Drug Therapy for Dyslipidemias T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259584732 LK accessbiomedicalscience.mhmedical.com/content.aspx?aid=1162539363 RD 2024/03/29 AB Dyslipidemia is a major cause of ASCVDs, such as CHD, ischemic cerebrovascular disease, and peripheral vascular disease. Cardiovascular disease represents the number one cause of death among adults in many developed nations (Mozaffarian et al., 2015). Both genetic disorders and lifestyle contribute to the dyslipidemias, including hypercholesterolemia and low levels of HDL-C.